Learn how CJC 1295 without DAC and ipamorelin dosage is typically researched, including common ratios, timing, and safety notes for lab studies.
A typical CJC-1295 without DAC and ipamorelin dosage in research protocols is about 100 mcg of CJC-1295 without DAC paired with 100–200 mcg of ipamorelin, injected two to three times per day. CJC-1295 without DAC is also written as Mod GRF 1-29, and ipamorelin is a selective ghrelin-receptor agonist, so the two work through different receptors. Neither peptide is FDA-approved for human use in the United States, which means the numbers below describe research summaries and user-reported logs rather than a clinical prescription.
What Each Peptide Does in Research Settings
CJC-1295 without DAC is a modified growth hormone-releasing hormone analog with a short half-life of roughly 30 minutes. Ipamorelin triggers a pulse of growth hormone release without strongly raising cortisol or prolactin in animal models, which is one reason it is studied alongside a GHRH analog.
Because the two compounds act on separate receptors, animal data suggest their effect on growth hormone release is additive rather than redundant. That is the main reason they appear together so often in the same protocol. For background on how the long-acting version differs, compare cjc-1295 ipamorelin with dac or without before choosing a reference point.
Typical Dosage Ranges Reported in Research
Reported protocols cluster in a fairly narrow band. The table below summarizes the numbers that appear most often in research write-ups and community logs.
| Peptide | Common research dose | Frequency | Notes |
|---|---|---|---|
| CJC-1295 without DAC | 100 mcg | 2–3 times daily | Short half-life; often timed to natural GH pulses |
| Ipamorelin | 100–200 mcg | 2–3 times daily | Frequently matched to the CJC-1295 dose |
| Combined per injection | 200–300 mcg | 2–3 times daily | Typical anchors are pre-sleep and pre-workout |
An exact 1:1 ratio is not required by any published protocol. Equal amounts are simply the easiest pattern to track, which is why a cjc-1295 no dac dosage of 100 mcg is so often paired with 100 mcg of ipamorelin.
Vial Math: Turning Milligrams Into Syringe Units
Reconstitution is where most of the confusion lives. A 10 mg blend vial containing 5 mg of CJC-1295 without DAC and 5 mg of ipamorelin fixes the ratio for you, while two separate vials let you adjust each peptide independently. Searches for cjc-1295 no dac ipamorelin 10mg blend dosage are usually people trying to work out how many units on a U-100 insulin syringe deliver a 100/100 mcg dose.
| Parameter | 10 mg blend in 3 mL of water | Separate 5 mg vials in 2.5 mL each |
|---|---|---|
| Concentration | 3.33 mg/mL | 2 mg/mL per vial |
| Volume for a 100 mcg dose of each | 0.06 mL (6 units) | 0.05 mL (5 units) from each vial |
| Syringe type | U-100 insulin syringe | U-100 insulin syringe |
Reconstitution volume changes everything, so the same 10 mg vial can deliver very different unit counts depending on how much bacteriostatic water is added. Doubling the water volume halves the concentration and doubles the number of units per dose. Always record the exact volume you used, because recalculating later from memory is where dosing errors happen.
Timing and Frequency
Because CJC-1295 without DAC clears quickly, timing matters far more than it does with the DAC version. Most protocols anchor injections to natural growth hormone pulses: one dose before sleep, with an optional second dose after waking or before training.
- Pre-sleep dosing is the most consistently reported pattern across protocols.
- Fasted dosing is common in community write-ups, on the theory that insulin blunts the GH response.
- A two-hour gap after the last meal is a frequently cited rule of thumb.
Threads asking about the cjc-1295 ipamorelin dosage per day reddit typically settle on two injections daily, with three as an upper bound in higher-dose logs. The DAC version is dosed far less often, usually once or twice a week, which is a meaningful difference for anyone comparing the two formats.
Why Bodybuilders Research This Pair
In fitness communities the appeal mirrors other growth hormone secretagogues: reported improvements in recovery, sleep quality, and body composition. Forums discussing a cjc-1295 without dac dosage bodybuilding approach commonly describe 100 mcg of each peptide two or three times daily across an 8–12 week cycle.
The evidence base deserves honesty here. Human data on these peptides is limited, most supporting research is in animals, and no large controlled human trial has confirmed meaningful body composition changes. Research peptides are not a shortcut around training, nutrition, and sleep.
Side Effects and Safety Considerations
- Injection-site redness, swelling, or itching is the most commonly reported issue.
- Some users report headache, flushing, or a short-lived increase in hunger after dosing.
- Because these compounds raise growth hormone and downstream IGF-1, long-term use carries theoretical risks that remain poorly studied in humans.
- Reconstituted peptides should be refrigerated and handled with sterile technique; research-grade products are not manufactured under pharmaceutical quality controls.
People who are pregnant or nursing, who take medications that affect blood sugar, or who manage any hormone-sensitive condition should not experiment with this class of compounds. A licensed physician who knows your history is the only person who can responsibly advise on growth hormone secretagogues.
The Bottom Line on Dosing
The most durable takeaway is that reported CJC-1295 without DAC and ipamorelin protocols are narrow and repetitive: 100 mcg of each peptide, two to three times daily, timed around sleep and training. Individual response varies widely, and none of these figures come from FDA-approved labeling. Treat any protocol you find online as a research reference point and confirm it with a healthcare professional before acting on it.
Frequently Asked Questions
What is a typical CJC-1295 without DAC and ipamorelin dosage?
Most research protocols pair about 100 mcg of CJC-1295 without DAC with 100–200 mcg of ipamorelin per injection, taken two to three times daily. That works out to roughly 400–900 mcg of combined peptide per day in the protocols most often cited. These figures come from research summaries and user logs, not from FDA-approved labeling, so they are not medical guidance.
Can CJC-1295 without DAC and ipamorelin be mixed in the same syringe?
Yes, the two peptides are commonly drawn into a single syringe in research settings because both are water-soluble and there is no reported interaction that degrades either one. Pre-mixed blend vials also exist, and they lock in a fixed 1:1 ratio. Mixing does not change the total dose, so the unit calculation still applies to the combined micrograms.
How long before bed should CJC-1295 without DAC and ipamorelin be taken?
Community protocols usually suggest dosing 30 to 60 minutes before sleep and at least two hours after the last meal. The goal is to line up the injection with the body's largest natural growth hormone pulse, which occurs early in sleep. Human data confirming a meaningful advantage for this timing is limited, so it remains a theory rather than a proven rule.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.